Tag: TG Therapeutics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to TG Therapeutics Inc.

TG Therapeutics Announces Publication of Final Results from the Phase 3 GENUINE Trial ...

Added to Collection on: 2021-02-23 12:22:30

Tags for this article:

Drugs
Orphan drugs
Health sciences
Health care
Breakthrough therapy
Tyrosine kinase inhibitors
Acrylamides
Ibrutinib
Pyrazolopyrimidines
Chronic lymphocytic leukemia
Rituximab
Bruton's tyrosine kinase
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
A peek at TG Therapeutics Inc. (TGTX): Who has invested in It?

Added to Collection on: 2021-03-12 22:40:15

Tags for this article:

Financial markets
Finance
Money
Stock market
Corporate finance
Stock
Short
NASDAQ
Initial public offering
Insider trading
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Ublituximab Added to Ibrutinib Demonstrates ORR Benefit for Relapsed/Refractory CLL

Added to Collection on: 2021-03-09 23:03:45

Tags for this article:

Orphan drugs
Drugs
Health sciences
Health care
Breakthrough therapy
Tyrosine kinase inhibitors
Acrylamides
Ibrutinib
Pyrazolopyrimidines
Chronic lymphocytic leukemia
Bruton's tyrosine kinase
Rituximab
TGTX-1101
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Brokerages Anticipate TG Therapeutics, Inc. (NASDAQ:TGTX) Will Post Earnings of -$0.52 Per Share

Added to Collection on: 2021-04-10 22:07:30

Tags for this article:

Finance
Financial ratios
Money
Financial markets
Corporate finance
Fundamental analysis
Stock market
Price?earnings ratio
Earnings per share
Stock
Short
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Cantor Fitzgerald Comments on TG Therapeutics, Inc.'s FY2022 Earnings (NASDAQ:TGTX)

Added to Collection on: 2021-05-08 15:39:20

Tags for this article:

Financial markets
Finance
Financial economics
Price?earnings ratio
Stock
Short
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of ...

Added to Collection on: 2021-06-18 18:00:00

Tags for this article:

Medical specialties
Immunosuppressants
Functional groups
Immunology
Multiple sclerosis
Anilides
Nitriles
Sanofi
Teriflunomide
CD20
Multiple sclerosis drug pipeline
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics, Inc. (NASDAQ:TGTX) is a favorite amongst institutional investors who own 84%

Added to Collection on: 2024-03-05 18:10:09

Tags for this article:

Stock market
Equity securities
Corporate finance
Private equity
Hedge funds
Stock
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
17500 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Bought by Strs Ohio

Added to Collection on: 2024-04-30 21:09:27

Tags for this article:

Equity securities
Stock market
Corporate finance
Financial capital
Private equity
Stock
NASDAQ
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Added to Collection on: 2025-06-06 23:40:09

Tags for this article:

ublituximab
Medicines and Healthcare products Regulatory Agency
Multiple sclerosis
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics' Subcutaneous BRIUMVI: A Game-Changer in MS Treatment and Market Expansion

Added to Collection on: 2025-09-08 18:42:29

Tags for this article:

Monoclonal antibodies
Orphan drugs
ublituximab
Multiple sclerosis
TG Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo